Stay updated with breaking news from Authorized Representative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Allahabad High Court has held that if the invoice accompanying the goods contains all the details of the vehicle then not filing of Part-B of the e-way bill is a technical error without any...
Practical guidance for institutions navigating bispecific therapy integration without prior experience is provided.
Medical experts dissect critical strategies for monitoring for potential adverse events with bispecific antibodies in a comprehensive panel discussion.
Considerations for enhancing bispecific drug effectiveness through strategic EMR utilization in healthcare are explored.
A panel discussion covers considerations within REMS programs aimed at minimizing risks associated with bispecific therapy. NOTE: Not all FDA-approved bispecific antibodies are associated with a REMS protocol.